Task: Answer the multiple choice question.
Query: Which drug exhibits a 18.966\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. O=C(OCCOCCN=C1NS(=O)(=O)c2ccccc21)c1ccncc1
b. Cc1ccc(SCCNC(=S)Nc2ccc(C)c(C)c2)cc1
c. CCOc1cc(NC(=S)NCCCN2CCOCC2)c(OCC)cc1NC(=O)CC(C)C
Answer: c. CCOc1cc(NC(=S)NCCCN2CCOCC2)c(OCC)cc1NC(=O)CC(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1cc(NC(=S)NCCCN2CCOCC2)c(OCC)cc1NC(=O)CC(C)C
CCOc1cc(NC(=S)NCCCN2CCOCC2)c(OCC)cc1NC(=O)CC(C)C
N-[2,5-diethoxy-4-(3-morpholin-4-ylpropylcarbamothioylamino)phenyl]-3-methylbutanamide